In contrast to healthy individuals, who show strong bias to regulatory response to YKL-40, 50% of patients with RA exhibit polarisation towards Th1 phenotype (van Bilsen et al. 2004). This evidence concerns the gene CHI3L1 and rheumatoid arthritis.